Skip to main content

Advertisement

Factors determining recurrence in transient global amnesia

Abstract

Background

Aetiology of transient global amnesia (TGA) remains uncertain, though many have been proposed, including ischaemic, migrainous or epileptic pathologies.

Methods

We attempted to determine risk factors for TGA, as well as prognostic factors that may cause recurrence. We evaluated clinical history, family history and magnetic resonance diffusion-weighted imaging (DWI) studies of 93 prospective patients with TGA. Patients were followed from 2004 to 2016. Fifteen of 93 (16%) patients experienced a recurrence of TGA.

Results

Among precipitating events, physical activities inducing Valsalva-like manoeuvres were most common, followed by emotional stress. Eighty-four patients had possible comorbidities or risk factors for TGA, though no single risk factor was ubiquitous. Risk factors associated with recurrence were head injury (isolated vs. recurrent, 16.7% vs. 53.5%, p < 0.01), depression (isolated vs. recurrent, 15.4% vs 46.7%, p = 0.01) and family history of dementia (isolated vs. recurrent, 20.5% vs. 46.7%, p = 0.03). Of 15 patients with confirmed recurrent TGA, two developed dementia and four subjective memory impairment. DWI lesions were observed in 24 patients and were located anywhere within the hippocampus.

Conclusions

DWI lesions were not significantly associated with outcomes (recurrence, subjective memory impairment, dementia). We have found that depression, previous head injury and family history of dementia may predict TGA recurrence.

Peer Review reports

Background

Transient global amnesia (TGA) presents as sudden onset anterograde amnesia, with some features of retrograde amnesia, without residual cognitive impairment, of duration < 24 h. Typically, it occurs in individuals aged 50–80 years, with decreased incidence in younger and older populations [1, 2]. Meta-analysis has found no predominance for either gender [1]. The estimated minimum annual incidence of TGA is 3.4 per 100,000, though this is likely to be much higher as some people will not present to the hospital and others will be misdiagnosed [3]. While TGA occurs as a single event for many, estimates of recurrence have ranged from 2.9 to 26.3%, but some studies were retrospective [4,5,6,7,8].

Imaging investigations are used to support the clinical diagnosis of TGA. Diffusion-weighted imaging (DWI) on magnetic resonance imaging (MRI) provides specific, consistent findings of 1–5 mm focal lesion in the hippocampal CA-1 sector, which resolve 7–10 days after onset of TGA, with no long-term structural changes [1, 9, 10]. It is hypothesized that, as these neurons are in locations vital for memory consolidation, small lesions may significantly impair memory function, [10] though any effects on prognosis are unknown. For instance, memory and executive function impairment may objectively last up to five days post-TGA onset, despite patients subjectively reporting normal memory [9, 11]. Other patients might develop long-lasting memory problems, especially those with recurrence [12, 13].

Multiple mechanisms have been proposed for the aetiology of TGA. One hypothesis is that retrograde venous flow leads to venous congestion, possibly due to increased thoracic pressure or jugular valve incompetence, which in turn causes a transient ischemia due to hypoperfusion [1, 3, 14,15,16,17,18]. Support for this comes from the observation that many TGA cases are precipitated by Valsalva-like activities, particularly physical or emotional stressors, which would temporarily cause thoracic-pressure elevation [1, 3, 14,15,16]. Ischaemia from thromboembolism constitutes a contrasting hypothesis on pathogenesis [13, 19]. Some studies have found TGA patients to have higher vascular risk factors and greater frequency of carotid atherosclerosis, suggesting an atherosclerotic embolic event as a cause [4, 20]. One final hypothesis is that TGA is a type of migrainous aura, occurring due to cortical spreading depression, leading to cellular metabolic stress in vulnerable CA-1 sector neurons [9, 18, 21,22,23,24]. Genetics may also contribute to susceptibility, based on observations from limited case studies [15, 25,26,27].

Risk factors that might predispose to TGA recurrence are speculative. In those with recurrence, the presence of multiple risk factors may increase susceptibility. These include continued physical and emotional stressors, arterial hypertension and jugular vein incompetence [1, 2, 4, 6].

To date, TGA research has focused largely on aetiology and pathophysiology, yet our understanding remains incomplete. Few studies have focused on management, prognosis or clinical improvements that can be made to assist healthcare staff in identifying TGA patients more accurately. By identifying patients with recurrence of TGA and comparing them with patients who only experienced a single episode, this study aimed to establish possible risk factors for TGA and its recurrence, so that these patients can recognized and educated on first presentation, with the goal of improving prognostic outcomes and minimising recurrence.

Methods

Subjects

Between 2004 and mid-2016, 107 patients presenting with acute memory dysfunction to Joondalup Health Campus Emergency Department (ED) or a neurology outpatient clinic were prospectively screened and recruited into the study; patients having their first attack between 2004 and mid-2016. The supervising neurologist was responsible for making the clinical diagnosis, based on previously published definitions of TGA [2].

Initial assessment

All patients provided written informed consent to participate in this research. They were interviewed, and the following information was collected: demographic data; details of the episode (duration, symptoms, prior activity); past medical history; family history; and smoking history. A series of investigations were performed after each episode, including MRI with DWI. Consent was obtained from each participant to store results in a secure database. Additional information was obtained from the patients’ ED admission, in instances when they had presented to the hospital.

Follow-up

In July 2015, the follow-up period commenced. Patients were contacted by telephone to check if there had been any recurrence of an acute amnestic state, to collect any information not gathered from their files and to determine if they had experienced any deterioration in memory. Numbers achieved in follow-up are shown in Fig. 1.

Fig. 1
figure1

Patient recruitment

Statistical analysis

In comparing data groups, descriptive analyses, namely chi-square or Fisher’s exact test with hypergeometric distribution, were used to test the distribution of a factor. Statistical significance was determined at p < 0.05.

Results

History of presentation

Total study population

In a cohort of 102 patients presenting with a transient amnestic state, 93 had experienced one or more episodes of TGA. Mean age of TGA onset was 59.5 (SD 10.3, range 17–78) years, among 49 men and 44 women. In total, these 93 people experienced 117 episodes of clinically diagnosed TGA and 18 recurrent episodes of amnesia, not otherwise specified. Median duration of TGA was 4.5 (IQR: 2–6.5) hours.

In 85 (73%) of episodes, there was an identifiable precipitating event, including: stress (36%); exercise (18%); housework (17%); feeling unwell, often associated with nausea or vomiting (16%); sexual intercourse (8%); hot shower (6%), coughing episode (5%); swimming in cold water (3%); and exposure to chemicals such as fresh paint (2%). Headaches were present either just prior to or during 21% of episodes.

Of the clinical features, repetitive questioning (88%) and disorientation to the day’s events (81%) were most commonly reported. Patients also displayed disorientation to place (54%), day (30%), time (28%), date (26%), and confusion (47%). Anxiety was less commonly reported (3%). No abnormal neurological signs were elicited during the episodes.

When compared as percentage prevalence values, a number of vascular and other risk factors were higher among the TGA cohort than the general population, as described by Australian Bureau of Statistic’s data [28]. These included hypertension, type 1 and 2 diabetes mellitus, dyslipidaemia, transient ischaemic attack, stroke, ischaemic heart disease, depression, anxiety and migraine (Fig. 2a). The Australia Bureau of Statistics did not offer prevalence of these comorbidities by age, therefore our results were compared with the population as a whole.

Fig. 2
figure2

Frequencies (%) of comorbidities: a in patients compared to the general population (Australian Bureau of Statistics [29]); and b in patients with recurrent (n = 15) versus single-episode transient global amnesia (n = 78) p-values were calculated using the hypergeometric distribution of Fisher’s exact test

In total, three (3.2%) patients were later diagnosed with dementia of the Alzheimer’s type, based on the clinical, syndrome functional decline and neuropsychology. Twenty-four (25.8%) had subjective memory deficits only, after neuropsychological testing.

Recurrent episodes

Among the 93 patients with TGA, 15 (16%) had recurrent TGA, with 39 episodes in total. The demographics of this group, and the duration of their TGA episodes, were similar to those with solitary TGA (Table 1). Stress (marital status, financial status, relationship, children, work, or a combination) was also the most common precipitating element among those with recurrence. Headache was less frequently noted, with less than a third frequency compared to the isolated event group (isolated vs. recurrent, 27% vs. 8%).

Table 1 Patient demographics, history of presenting complaint and past medical history for patients with a single episode of TGA compared to those with recurrent attacks

Regarding clinical features, disorientation to time, disorientation to the day’s events and headache were more commonly documented as having occurred in the isolated-episode group (Table 1).

A history of depression and previous head injury were significantly higher in the multiple-TGA group, compared to the single episode group (Fig. 2b). Recurrent TGA was associated with a family history of dementia (Table 2). Neither family history of TGA nor cardiovascular disease were associated with recurrent TGA. Within our cohort, family history of TGA existed for five patients through a first degree relative, one patient through a cousin, and another patient through two first degree relatives and a cousin. The latter patient also had recurrent TGA; the other six had a single episode.

Table 2 Family history in patients with TGA

Of the 15 with recurrent TGA, two (5.1%) were later diagnosed with dementia of the Alzheimer type and four (10.3%) reported subjective memory deficits. Among the 78 with an isolated episode, one (1.3%) was later diagnosed with dementia of the Alzheimer type and 20 (25.6%) reported subjective memory deficits.

Neuroimaging

Total study population

MRI studies were performed 120 times, with patients receiving multiple investigations after an episode. Eight (6.7%) were performed within 24 h, 50 (41.2%) were performed 1–10 days after the episode, and 62 (51.7%) were performed after 10 days had passed. Median time between presentation and MRI was 4 days (IQR: 2–24). 24 of 93 patients had DWI spots, 50% of whom had a positive smoking history (p = 0.08) and 42% had hypertension (p = 0.05). 25 of 26 positive DWIs were taken within 10 days of the episode (96.2%; p < 0.0001), with only one (3.8%) positive DWI occurring outside this time, at day 12. In 21 scans, a single spot was seen; two spots in four scans; and three spots in two scans. Average size of spots was 3.5 ± 1.6 mm (mean ± standard deviation). All were in the hippocampus, though the specific location varied anywhere from the hippocampal head to tail; 12 were left-sided, 24 were right-sided. DWI spots had no greater frequency in patients who went on to develop recurrence, dementia or subjective memory problems (Table 3).

Table 3 MRI results within 15 days of symptom onset, compared with outcomes in TGA patients

Recurrent episodes

One patient had recurrence of lesions on DWI with their second episode.

Discussion

Our results for precipitating events leading to TGA were compatible with findings of others [1,2,3,4, 14, 25]. Most of our TGA episodes were precipitated by an identifiable event, most commonly an emotional or physical stressor involving Valsalva-like manoeuvres. Some emotional stressors occurred immediately before the attack; others were more longer-term, including home, family and workplace conflicts – it has been suggested that these increase susceptibility to TGA and its recurrence [1, 30]. A history of depression and head injury were significantly increased among those with recurrence.

Approximately one-third of our cohort had a history of migraine; a much greater proportion than in the general population. Our data supports a pathophysiological association between migraine and TGA, probably through spreading depression [15, 21, 24, 27, 28]. Interestingly, one-fifth of our patients had attacks of TGA with headaches.

Other studies have found increased rates of cerebrovascular risk factors in TGA patients [5, 29]; a finding that has not been replicated [2, 6]. Some observers have found increased incidence of ischaemic heart disease in recurrent TGA [4, 20]. However, we did not observe any association with cerebrovascular risk factors.

Incidence of TGA is low, so in cases where multiple family members are affected, it raises questions of whether there is a direct or indirect genetic component. The small sample size of patients with family history of TGA meant statistical analysis was not possible. The presence of TGA in families is not well studied. We have found a complex presentation of TGA in families which requires more investigation. Of note, a family history was found to be significantly associated with the occurrence of TGA, a finding not previously identified.

Family history of dementia was found to be associated with recurrence of TGA. The genetic predisposition of TGA is unknown; however, it is recognised that APOE e4 is a risk factor for dementia [31]. Therefore, we propose that the link between genetic factors operable in TGA and its relationship to dementia family history may be through an APOE e4-like mechanism.

Within our patient population, 28% had a second episode of amnesia, though in only 16% was the documentation strong enough to conclusively support that the patient had two or more episodes of TGA within the study’s duration. The reason for this discrepancy is that, while patients and their family members could recall another episode of amnesia, they could not remember other details. Recall bias might have influenced their recollection of the facts.

Another hypothesis for TGA pathogenesis relates to susceptibility of blood vessels around the CA-1 region of the hippocampus, based on observations of DWI lesions in this area [9, 18]. Our findings are not consistent with this hypothesis, with the 35 DWI spots observed located throughout the hippocampus, from head to tail.

All but one spot was detected within one week of TGA onset. We were not able to assess the minimum MRI latency for positive lesions; however, infarctions on MRI within 24 h may only have 82% sensitivity, creating a high frequency of false-negatives in this time frame [32,33,34]. Repeat MRIs, when performed after one week, showed most lesions had disappeared, in keeping with previous findings. Sensitivity of DWI for acute infarctions after 24 h ranges from 88 to 100%, and specificity is 86-–100% [35, 36].

Factors noted to increase incidence of positive DWIs include a history of smoking and systolic blood pressure ≥ 140 or diastolic blood pressure ≥ 90 mmHg [33]. In our patient population, 50 and 42% of the patients with positive DWI had a history of smoking or hypertension, respectively.

Nevertheless, among TGA patients with MRIs performed within 10 days from onset, 41% (25/61) had a visible, hyperintense lesion. False-negative DWIs may explain why some patients do not show areas of hyperintensity.

Posterior circulation infarctions are much likelier to give false-negative DWIs than an anterior circulation infarction [34]. Blood supply to the hippocampus is complicated as it is variable. In most the posterior cerebral artery (PCA), or a branch thereof, supplies the hippocampus. In some there are contributions from the anterior choroidal artery [37]. The anterior hippocampal artery, branching from the PCA, supplies the hippocampal head, whilst the middle and posterior hippocampal arteries supply the hippocampal body and tail, and have numerous anastomoses [38]. Therefore, small infarctions in the body or tail of the hippocampus might not show DWI positivity because of these anastomoses.

Previous studies have suggested recurrence might be associated with longer-term changes to memory, ranging from verbal and non-verbal memory impairment to dementia [12, 13]. Our data do not support that TGA is a risk factor for dementia. Among the group of people who reported subjective memory impairment, anxiety from the experience of TGA may leave patients doubting their short-term memory capabilities.

Conclusions

We believe TGA is a distinctive clinical syndrome arising from different mechanisms. It may recur in 16% of those who have a background of head injury, depression or a family history of dementia.

Availability of data and materials

The dataset supporting the conclusions of this article is electronically stored and is password protected. The de-identified dataset used during the current study is available from the corresponding author on reasonable request.

Abbreviations

DWI:

Diffusion-weighted imaging

ED:

Emergency department

IQR:

Interquartile range

MRI:

Magnetic resonance imaging

TGA:

Transient global amnesia

References

  1. 1.

    Quinette P, Guillery GB, et al. What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases. Brain. 2006;129:1640–58.

  2. 2.

    Hodges JR, Warlow CP. Syndromes of transient amnesia: towards a classification. A study of 153 cases. JNNP. 1990;53:834–43.

  3. 3.

    Hodges JR, Warlow CP. The aetiology of transient global amnesia. A case-control study of 114 cases with prospective follow-up. Brain. 1990;113:639–57.

  4. 4.

    Agosti C, Akkawi NM, Borroni B, Padovani A. Recurrency in transient global amnesia: a retrospective study. Eur J Neurol. 2006;13:986–9.

  5. 5.

    Melo TP, Ferro JM, Ferro H. Transient global amnesia: A case control study. Brain. 1992;115:261–70.

  6. 6.

    Zorzon M, Antonutti L, Mase G, et al. Transient global amnesia and transient ischemic attack. Natural history, vascular risk factors, and associated conditions. Stroke. 1995;26:1536–42.

  7. 7.

    Gandolfo C, Caponnetto C, Conti M, et al. Prognosis of transient global amnesia: a long-term follow-up study. Eur Neurol. 1992;32:52–7.

  8. 8.

    Hinge HH, Jensen TS, Kjaer M, et al. The prognosis of transient global amnesia: results of a multi-center study. Arch Neurol. 1986;43:673–6.

  9. 9.

    Bartsch T, Alfke K, Stingele R, et al. Selective affection of hippocampal CA-1 neurons in patients with transient global amnesia without long-term sequelae. Brain. 2006;129:2874–84.

  10. 10.

    Scheel M, Malkowsky C, Klingebiel R, et al. Magnetic resonance imaging in transient global amnesia: lessons learned from 198 cases. Clin Neuroradiol. 2012;22:335–40.

  11. 11.

    Jäger T, Bazner H, Kliegel M, et al. The transience and nature of cognitive impairments in transient global amnesia: a meta-analysis. J Clin Exp Neuropsychol. 2009;31:8–19.

  12. 12.

    Borroni B, Agosti C, Brambilla C, et al. Is transient global amnesia a risk factor for amnestic mild cognitive impairment? J Neurol. 2004;251:1125–7.

  13. 13.

    Mathew NT, Meyer JS. Pathogenesis and natural history of transient global amnesia. Stroke. 1974;5:303–11.

  14. 14.

    Agosti C, Borroni B, Akkawi NM, Padovani A. Cerebrovascular risk factors and triggers in transient global amnesia patients with and without jugular valve incompetence: results from a sample of 243 patients. Eur Neurol. 2010;63:291–4.

  15. 15.

    Donnet A. Transient global amnesia triggered by migraine in a French tertiary-care center: an 11-year retrospective analysis. Headache. 2015;55:853–9.

  16. 16.

    Lewis SL. Aetiology of transient global amnesia. Lancet. 1998;352:397–9.

  17. 17.

    Schreiber SJ, Doepp F, Klingebiel R, Valdueza JM. Internal jugular vein valve incompetence and intracranial venous anatomy in transient global amnesia. JNNP. 2005;76:509–13.

  18. 18.

    Yang YS, Kim SY, Kim JH. Ischemic evidence of transient global amnesia: location of the lesion in the hippocampus. J Clin Neurol. 2008;4:59–66.

  19. 19.

    Shuttleworth EC, Wise GR. Transient global amnesia due to arterial embolism. Arch Neurol. 1973;29:340–2.

  20. 20.

    Winbeck K, Etgen T, von Einsiedel HG, et al. DWI in transient global amnesia and TIA: proposal for an ischaemic origin of TGA. JNNP. 2005;76:438–41.

  21. 21.

    Dalla Volta G, Zavarise P, Ngonga G, et al. Transient global amnesia as a presenting aura. Headache. 2014;54:551–2.

  22. 22.

    Liu YB, Disterhoft JF, Slater NT. Activation of metabotropic glutamate receptors induces long-term depression of GABAergic inhibition in hippocampus. J Neurophysiol. 1993;69:1000–4.

  23. 23.

    Gupta M, Kantor MA, Tung CE, et al. Transient global amnesia associated with a unilateral infarction of the fornix. Front Neurol. 2014;5:291.

  24. 24.

    Montagna P, Cerullo A, Cortelli P. Transient global amnesia occurring as migraine aura. J Headache Pain. 2000;1:57–9.

  25. 25.

    Davies RR, Larner AJ. Familial transient global amnesia. Case Rep Neurol. 2012;4:236–9.

  26. 26.

    Stracciari A, Rebucci GG. Transient global amnesia and migraine: Familial incidence. JNNP. 1986;49:716.

  27. 27.

    Dupuis MJ, Pierre P, Gonsette RE. Transient global amnesia and migraine in twin sisters. JNNP. 1987;50:816–7.

  28. 28.

    Australian Bureau of Statistics. National Health Survey. Canberra: Australian Bureau of Statistics; 2015.

  29. 29.

    Jang J-W, Park SY, Hong J-H, et al. Different risk factor profiles between transient global amnesia and transient ischemic attack: a large case-control study. Eur Neurol. 2014;71:19–24.

  30. 30.

    Inzitari D, Pantoni L, Lamassa M, et al. Emotional arousal and phobia in transient global amnesia. Arch Neurol. 1997;54:866–73.

  31. 31.

    Huang W, Qiu C, von Strauss E, et al. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study. Arch Neurol. 2004;61:1930–4.

  32. 32.

    Bulut HT, Yildirim A, Ekmekci B, et al. False-negative diffusion-weighted imaging in acute stroke and its frequency in anterior and posterior circulation ischemia. J Comput Assist Tomogr. 2014;38:627–33.

  33. 33.

    Zuo L, Zhang Y, Xu X, et al. A retrospective analysis of negative diffusion-weighted image results in patients with acute cerebral infarction. Sci Rep. 2015;5:8910.

  34. 34.

    Oppenheim C, Stanescu R, Dormont D, et al. False-negative diffusion-weighted MR findings in acute ischemic stroke. AJNR Am J Neuroradiol. 2000;21:1434–40.

  35. 35.

    Lovblad KO, Laubach HJ, Baird AE, et al. Clinical experience with diffusion-weighted MR in patients with acute stroke. AJNR Am J Neuroradiol. 1998;19:1061–6.

  36. 36.

    Shintani S, Yokote H, Hanabusa K, Shiigai T. False-negative and false-positive diffusion-weighted MR findings in acute ischemic stroke and stroke-like episodes. J Rural Med. 2005;1:27–32.

  37. 37.

    Duvernoy H, Cattin F, Risold P. The human hippocampus: functional anatomy, vascularisation and serial sections with MRI. 4th ed. Berlin Heidelberg: Springer-Verlag; 2013.

  38. 38.

    Erdem A, Yasargil G, Roth P. Microsurgical anatomy of the hippocampal arteries. J Neurosurg. 1993;79:256–65.

Download references

Acknowledgements

We acknowledge the input of our biostatistician, Dr. Huei-Yang Chen, for his assistance in analysing the data.

Ethics and consent for participation

Ethics approval was obtained from the Joondalup Health Campus Human Research Ethics Committee (JHC-HREC), endorsed by Ramsay Corporate Services JHC-HREC No. 2011/1018. All methods were performed in accordance with the relevant guidelines and regulations of the JHC-HREC. Written informed consent was obtained from all participants. Information obtained from participants was internally collated into a database and analysed by our biostatistician.

Funding

The collection, analysis and preparation of manuscript for this research were funded by Neurodegenerative Disorders Research Pty Ltd.

Author information

RT collected, collated and analysed the data, and drafted the manuscript. PKP collected, collated and analysed the data; helped in drafting the manuscript and revised it. All authors have read and approved the manuscript.

Correspondence to Peter K. Panegyres.

Ethics declarations

Consent for publication

Not applicable.

Competing interests

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tynas, R., Panegyres, P.K. Factors determining recurrence in transient global amnesia. BMC Neurol 20, 83 (2020). https://doi.org/10.1186/s12883-020-01658-8

Download citation

Keywords

  • Transient global amnesia
  • Recurrent
  • Risk factors
  • Diffusion-weighted imaging
  • Dementia